Literature DB >> 7486877

Biased assessment of blinding in a randomized placebo-controlled trial of oral methotrexate in chronic progressive multiple sclerosis.

D W Dippel, P G Oomes, L H Visser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7486877     DOI： 10.1002/ana.410380521

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  1 in total

1.  Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.

Authors:  Nadinda A M van der Ende; Bob Roozenbeek; Olvert A Berkhemer; Peter J Koudstaal; Jelis Boiten; Ewoud J van Dijk; Yvo B W E M Roos; Robert J van Oostenbrugge; Charles B L M Majoie; Wim van Zwam; Hester F Lingsma; Aad van der Lugt; Diederik W J Dippel
Journal:  Stroke       Date:  2021-10-05       Impact factor: 7.914
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.